Tales from the Heart

Lisa Salberg sits down with whistleblower Dinesh Thaker to examine the hidden risks within the generic drug supply chain and why stronger oversight is urgently needed. Together, they discuss drug quality, patient safety, and how advocacy can help drive meaningful change in the healthcare system.   This conversation was recorded June 17, 2026.

Lisa Salberg and Dr. Steve Ommen discuss practical ways to stay healthy with HCM during the busy summer months. They also break down promising new drug research, explain what emerging biomarkers mean for patients, and share why planning ahead can help people with HCM enjoy life with greater confidence.   This conversation was recorded June 19, 2026.

Lisa Salberg sits down with Dr. Nicholas Smedira of the Cleveland Clinic to explore how HCM surgery has evolved over the past three decades. They discuss myectomy, myosin inhibitors, surgical innovation, patient selection, and why experience and high-volume centers continue to matter in achieving the best outcomes for patients.   This conversation was recorded June 8, 2026.

Lisa Salberg welcomes Dr. Ahmed "Sami" Abuzaid to discuss the growth of specialized HCM care in Alaska. They explore building a regional HCM program, expanding access to clinical trials, improving health equity, and what patients need to know about navigating care in remote communities.   This conversation was recorded June 5, 2026.

Lisa Salberg welcomes Dr. Christopher Kramer to discuss groundbreaking findings from the international HCMR Registry. They explore how cardiac MRI, scar burden, heart muscle mass, and biomarkers may improve risk prediction and help shape the future of personalized HCM care.   This conversation was recorded on May 29, 2026

Lisa Salberg and Dr. Alex de Feria explore the latest developments in HCM care, from promising non-obstructive HCM therapies to the challenges of recognizing symptoms, managing medications, and assessing sudden cardiac death risk. They also discuss clinical trials, fibrosis research, and why the future of HCM treatment has never looked brighter.   This conversation was recorded May 28, 2026.

Host Lisa Salberg talks with Dr. Ronald H. Wharton about building a nationally recognized HCM Center of Excellence at Northwell Health on Long Island. They discuss patient education, new myosin inhibitor therapies, clinical trials, and why specialized HCM care can change lives for patients and families.   This conversation was recorded 5/21/26

Lisa Salberg welcomes Steven Kelley and Matt Grant to discuss HCMA’s new discussion group for men 40-ish and under living with HCM. The conversation explores friendship, mental health, dating, devices, and building a supportive space where younger men can openly share their experiences and connect with others facing similar challenges.   This conversation was recorded May 15, 2026.

Lisa Salberg and Dr. Michael Ayers explore the rapidly evolving world of HCM treatment, from myosin inhibitors and clinical trials to AFib management and patient-centered care. The episode also dives into advocacy, drug safety concerns, and why personalized treatment strategies matter more than ever for people living with hypertrophic cardiomyopathy. This conversation was recorded May 15, 2026.

Lisa Salberg and Dr. Marty Maron break down the rapidly changing landscape of HCM treatment, including the growing role of myosin inhibitors and what new clinical trial data could mean for patients. The conversation also explores beta blockers, shared care models, Centers of Excellence, and why personalized treatment matters more than ever.   This conversation was recorded May 8, 2026.

Lisa Salberg welcomes Ram Khandelwal and Pallari Kamat for a global conversation about expanding HCM awareness and patient advocacy across India. The episode explores the challenges of diagnosis, healthcare access, and education while highlighting efforts to build stronger support systems for patients and families worldwide.   This conversation was recorded May 7, 2026.

Lisa Salberg and Dr. Marty Maron break down major new clinical trial results that could change treatment for patients with non obstructive HCM. They explain what the Acacia HCM trial found, why experts call it a transformative moment, and what the next steps could mean for patients around the world.   This conversation was recorded May 5, 2026.

Lisa Salberg and Dr. Matt Martinez break down how medical management for HCM is rapidly evolving, from traditional beta blockers to game-changing myosin inhibitors. They also preview what’s next, including emerging drugs, clinical trials, and new approaches that could reshape care in the near future.   This conversation was recorded May 1, 2026

Lisa Salberg and Dr. Ethan Rowin break down new data on atrial fibrillation risk in patients taking myosin inhibitors for HCM. They explain what the latest research shows, how risk compares to traditional care, and what patients should watch for as treatment options continue to evolve.   This conversation was recorded April 28, 2026.

Lisa Salberg is joined by Lynda Neuhausen and Vi Tang to launch a new discussion group focused on the genetics of hypertrophic cardiomyopathy. They explore the science behind genetic testing, the emotional impact on families, and how open conversation can help patients navigate uncertainty and risk together.   This conversation was recorded April 24, 2026.

Lisa Salberg and Dr. Steve Ommen reflect on the legacy of a cardiology pioneer who helped shape modern HCM care, while discussing the latest in genetics, diagnosis, and treatment. They break down how far the field has come and what patients should understand as care continues to evolve.   This conversation was recorded April 24, 2026

Lisa Salberg and Dr. Harry Lever take a hard look at generic drug quality and why consistency matters for people living with HCM. They break down real-world risks, what patients should watch for at the pharmacy, and how policy changes could improve safety nationwide.   This conversation was recorded April 17, 2026.

Lisa Salberg and Dr. Ahmed Masri break down the SONATA HCM clinical trial and a new approach that targets metabolism, not just pressure, in the heart. They explain who may qualify, what to expect, and why patient participation is critical to advancing better treatments for both obstructive and non-obstructive HCM.   This conversation was recorded April 14, 2026

Lisa Salberg and Dr. Marty Maron break down the latest HCM developments from ACC, including emerging myosin inhibitors, AI in imaging, and new approaches to fibrosis and genetic therapies. They also explain what these advances mean for patients now and how to prepare for a rapidly evolving treatment landscape.   This conversation was record April 10, 2026

Lisa Salberg and Dr. Alex de Feria walk through how patients can stay proactive with hypertrophic cardiomyopathy—from annual testing and symptom tracking to understanding when to act. They break down real-world decision making, hidden symptoms, and how evolving care strategies can help patients stay ahead of their condition.   This conversation was recorded March 26, 2026.

Lisa Salberg and Dr. Marty Maron break down new research reshaping how HCM is treated, from long-standing beta blockers to emerging targeted therapies. They also walk through arrhythmia risks, monitoring, and prevention—giving patients a clearer roadmap for managing symptoms and long-term outcomes in a rapidly changing care landscape. Conversation recorded March 13, 2026

Lisa Salberg sits down with Senator Anthony Bucco to discuss why Heart Month and knowing your family heart health history can save lives. They explore New Jersey’s leadership in cardiac screening laws, the importance of early detection for HCM, and ongoing efforts to improve insurance access and patient protections.   This conversation was recorded Feb. 20, 2026.

Lisa Salberg and Dr. Marty Maron reflect on Heart Month, HCM Awareness Day, and the rapid evolution of treatment options. They discuss new therapies, clinical trials, patient empowerment, and why clarity and lifelong care remain essential in the journey with hypertrophic cardiomyopathy.   This conversation was recorded Feb. 20, 2026.

Lisa Salberg and Dr. Marty Maron reflect on Heart Month, HCM Awareness Day, and the rapid evolution of treatment options. They discuss new therapies, clinical trials, patient empowerment, and why clarity and lifelong care remain essential in the journey with hypertrophic cardiomyopathy.   This conversation was recorded Feb. 13, 2026

Host Lisa Salberg talks with author Dr. Matt Martinez about living with hypertrophic cardiomyopathy while balancing family, career, and advocacy. The conversation explores personal perspective, patient empowerment, and how sharing lived experience can help others better understand and navigate an HCM diagnosis.   This conversation was recorded Feb. 6, 2026.